COMMUNIQUÉS West-GlobeNewswire

-
La coentreprise Pure Sunfarms d'Emerald Health Therapeutics a réalisé un chiffre d'affaires de 32 millions $ au deuxième trimestre, une marge d'EBITDA de 78 %, un coût de production global de 0,65 $/g et un troisième trimestre de rentabilité consécutif
13/08/2019 -
Precipio Pathology Sales Metrics Demonstrate Continuous Improvement in Q2 2019
13/08/2019 -
Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2020
13/08/2019 -
Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019
13/08/2019 -
North American Partners in Anesthesia (NAPA) welcomes Dan Gofman as new Senior Vice President of Mergers & Acquisitions
13/08/2019 -
Better Choice Company Enters Research Agreement with Green Element to Test Anxiety-Reducing Potential in CBD Dog Treats
13/08/2019 -
Cleveland Clinic and Bravo Collaborate to Offer Wellness Program to Employers Nationwide
13/08/2019 -
Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board
13/08/2019 -
Precipio Announces Q2-2019 Corporate Update Call for Shareholders
13/08/2019 -
BioNovelus Announces Removal of Yield Sign
13/08/2019 -
Imprivata Complements Microsoft Azure Experience with Day One Identity Management
13/08/2019 -
HealthEquity Sets Date to Announce Second Quarter Results Fiscal Year 2020
13/08/2019 -
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
13/08/2019 -
Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
13/08/2019 -
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
13/08/2019 -
New IHIT Report Examines Hospital Cybersecurity Challenges and Identifies Next Steps in Protection
13/08/2019 -
Ultragenyx to Present at Wedbush PacGrow Healthcare Conference
13/08/2019 -
Aura Announces Pharmadrug Operational & Investor Relations Update
13/08/2019 -
Novan’s Phase 3 Molluscum Pivotal Program Completes Enrollment
13/08/2019
Pages